| Company |
Type |
Type |
| Albiorex, LLC |
Equity Raise Preferred A |
$750,000 |
| Albiorex, LLC |
Equity Raise Common B |
$848,000 |
| Albiorex, LLC |
Equity Preferred B |
$315,000 |
| Apollo Pharmaceutical Inc. |
Equity Raise Common |
$1,530,000 |
| Apollo Pharmaceutical Inc. |
Equity Preferred A |
$3,500,000 |
| Apollo Pharmaceutical (Canada) Inc. |
Series B Preferred Stock |
$600,000 |
| Apollo Pharmaceutical (Canada) Inc. |
Equity Raise Preferred B |
$850,000 |
| DNAP Print Genomics, Inc. |
Convertible debenture and warrants |
$8,000,000 |
| DNAP Print Genomics, Inc. |
Convertible debenture and warrants option |
$4,000,000 |
| DNAP Print Genomics, Inc. |
Equity Raise Preferred |
$290,000 |
| DNAP Print Genomics, Inc. |
Convertible debenture and warrants |
$35,000,000 |
| Fovioptics, Inc. |
Equity Raise Preferred A |
$4,290,000 |
| ImagiNail Corporation |
Equity Raise Preferred B |
$1,250,000 |
| Residential/Commercial Developer |
PFD membership interest |
$2,500,000 |
| UTEK Corporation |
IntraData MGT acquisition |
$2,500,000 |
| UTEK Corporation |
Pharma - Transfer acquisition |
$2,500,000 |
| Commercial Developer |
Senior Debt Raise |
$90,000,000 |
| Residential/Commercial Developer |
Senior and Subordinated Debt Raise Ashley Glen |
$20,500,000 |
| CXA Group, LLC |
Equity Raise Preferred B |
$700,000 |
|
|
TOTAL: |
$179,923,000 |